A5012676247- Antifungal resistance and susceptibility
- Fungal Infections and Studies
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- Entomopathogenic Microorganisms in Pest Control
- Parvovirus B19 Infection Studies
- Autoimmune and Inflammatory Disorders Research
- Immune Cell Function and Interaction
- Respiratory viral infections research
- Biosensors and Analytical Detection
- Enterobacteriaceae and Cronobacter Research
- Parasitic Diseases Research and Treatment
KU Leuven
2021-2022
Jessa Hospital
2020
Imelda Hospital
2018-2019
We evaluated the quantitative DiaSorin Liaison severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen test in symptomatic and asymptomatic individuals consulting their general practitioners (GPs) during a period of stable intense virus circulation (213/100,000 habitants per day). Leftover reverse transcription-PCR (RT-PCR) positive (n = 204) negative 210) nasopharyngeal samples were randomly selected among fresh routine collected from patients GPs. Samples tested on XL...
From early 2020, a high demand for SARS-CoV-2 tests was driven by several testing indications, including asymptomatic cases, resulting in the massive roll-out of PCR assays to combat pandemic. Considering dynamic viral shedding during course infection, report cycle threshold (Ct) values rapidly emerged. As Ct can be affected number factors, we considered that harmonization semi-quantitative results across laboratories would avoid potential divergent interpretations, particularly absence...
Triazole-resistance has been reported increasingly in Aspergillus fumigatus. An international expert team proposed to avoid triazole monotherapy for the initial treatment of invasive aspergillosis regions with >10% environmental-resistance, but this prevalence is largely unknown most American and African countries. Here, we screened 584 environmental samples (soil) from urban rural locations Mexico, Paraguay, Peru Latin America Benin Nigeria Africa triazole-resistant A. Samples were using...
Candida auris is a difficult-to-identify, emerging yeast and cause of sustained nosocomial outbreaks. Presently, not much data exist on laboratory preparedness in Europe. To assess the ability laboratories Belgium Luxembourg to detect this species, blinded C. strain was included regular proficiency testing rounds organized by Belgian public health institute, Sciensano. Laboratories were asked identify report isolate as they would routine clinical practice, if grown from blood culture. Of 142...